This four-day event features panel discussions and contributed sessions on the latest developments in health economics.
Cornerstone Research staff and experts will participate on multiple panels at ASHEcon, which provides a platform for sharing findings, methods, and insights in health economics and related topics.
Laurence Baker, Stanford University
18 June
- (Author) Abstract: “On What Basis Do Hospitals and Insurers Negotiate DRG Prices?”
JP Bruno, Cornerstone Research
17 June
- (Presenter) Session: “Being a Health Economist: Working in Government, Health Plans, Pharmaceuticals, Consulting Firms, Think Tanks and the Private Sector,” 3:30–5:00 PM
- (Presenting Author) Abstract: “How Leaky Is the Bucket? Network Effects of 340B Contract Pharmacies”
- (Author) Abstract: “Does 340B Status Affect Pharmacy Demand? Evidence from Medicare Part D Plans”
19 June
- (Chair) Session: “New Evidence of Impacts of 340B on Providers,” 8:30–10:00 AM
- (Author) Abstract: “Estimated Impact of New 340B Patient Definitions on the Size of the 340B Program in Medicare”
M. Kate Bundorf, Duke University
17 June
- (Discussant) Abstract: “Do Family Caregivers Subsidize Medicare Advantage Plans?”
- (Discussant) Abstract: “Association between Transition to a Value-Based Medication Benefit and Acute, Preventable Diabetes Complications”
18 June
- (Presenter) Session: “Meet the Editors,” 8:30–10:00 AM
- (Chair) Session: “Fertility Policies and Treatments Around the World: Evidence from the US, China, and Sweden,” 1:45–3:15 PM
- (Presenting Author) Abstract: “Racial Disparities in the Health Effects of Health Care Disruptions Among People Enrolled in Medicaid Due to Disability during the COVID-19 Pandemic”
- (Author) Abstract: “Racial and Ethnic Segregation in Ambulatory Health Care”
- (Discussant) Abstract: “Can Community Health Workers Affect Reproductive Health Decisions? Evidence from India”
- (Discussant) Abstract: “The Economics of Infertility: Evidence from Reproductive Medicine”
19 June
- (Chair) Session: “The Evolving Landscape of Integrated Care for Dual-Eligible Beneficiaries: 3 Medicare Advantage Models,” 12:00–1:30 PM
- (Author) Abstract: “Hospital Market Concentration and Access to Care for Low-Income Populations”
- (Author) Abstract: “The Relationship between Care Coordination in Medicare Special Needs Plans and Medicaid Spending: A North Carolina Case Study”
Alice Chen, University of Southern California
18 June
- (Author) Abstract: “Impact of Generic Drug Market Entry on Rebates for Brand Name Drugs”
Mark Duggan, Stanford University
18 June
- (Author) Abstract: “The Impact of Privatization: Evidence from the Hospital Sector”
Daniel Kessler, Stanford University
17 June
- (Presenting Author) Abstract: “The Effect of Organizations on Physician Prescribing: The Case of Opioids”
Darius Lakdawalla, University of Southern California
18 June
- (Presenter) Session: “Being a Health Economist: Working in Different Types of Departments and Schools,” 10:15–11:45 AM
Anup Malani, University of Chicago
17 June
- (Author) Abstract: “Understanding Health Care Fraud”
Sayeh Nikpay, University of Minnesota School of Public Health
17 June
- (Organizer/Chair) Session: “New Evidence on 340B and Safety-Net Providers,” 8:30–10:00 AM
- (Organizer/Chair) Session: “Emerging Issues in 340B Pharmacy,” 10:15–11:45 AM
- (Discussant) Abstract: “Net Spending and Sources of Growth in the 340B Drug Pricing Program”
- (Discussant) Abstract: “The Role of Clinician Peer Networks in Buprenorphine Adoption”
- (Discussant) Abstract: “Exploring the Rapid Growth of 340B Contract Pharmacies Among STD and HIV Clinics in the U.S. Safety Net”
- (Author) Abstract: “Does 340B Status Affect Pharmacy Demand? Evidence from Medicare Part D Plans”
- (Author) Abstract: “Hacked to Pieces? the Effects of Ransomware Attacks on Hospitals and Patients”
18 June
- (Chair) Session: “Policy Levers Affecting Provider Participation in Medicaid: Implications for Access and Equity,” 8:30–10:00 AM
- (Presenting Author) Abstract: “Only One Can Win – Medicaid Drug Rebates and 340B Discounts”
19 June
- (Organizer) Session: “New Evidence of Impacts of 340B on Providers,” 8:30–10:00 AM
- (Presenting Author) Abstract: “Estimated Impact of New 340B Patient Definitions on the Size of the 340B Program in Medicare”
- (Discussant) Abstract: “Impact of 340B Exposure on Treatment Cost of Medicare Patients with Cancer”
Cornerstone Research is a sponsor of this event, hosted by the American Society of Health Economists. For more information, please visit the event website.
Chicago
